Impaired gait kinematics in type 1 Gaucher's Disease

被引：17

作者：

Sorrentino, Pierpaolo ^{[1
,2
]}

Barbato, Antonio ^{[3
]}

Del Gaudio, Luigi ^{[1
]}

Rucco, Rosaria ^{[4
,5
]}

Varriale, Pasquale ^{[4
,5
]}

Sibilio, Michelina ^{[6
]}

Strazzullo, Pasquale ^{[3
]}

Sorrentino, Giuseppe ^{[4
,5
]}

Agosti, Valeria ^{[4
,5
]}

机构：

[1] Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Naples, Italy

[2] Vrije Univ Amsterdam Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands

[3] Univ Naples Federico II, Dept Clin Med, Naples, Italy

[4] Univ Naples Parthenope, Dept Motor Sci & Wellness, Naples, Italy

[5] Inst Hermitage Capodimonte, Naples, Italy

[6] Moscati Hosp, Div Pediat, Aversa, CE, Italy

来源：

JOURNAL OF PARKINSONS DISEASE | 2016年 / 6卷 / 01期

关键词：

Gaucher's disease; gait analysis; joint excursion; extrapyramidal system; Parkinson disease; parkinsonism; HEALTHY ELDERLY SUBJECTS; PARKINSONS-DISEASE; GLUCOCEREBROSIDASE MUTATIONS; INVOLVEMENT; CARRIERS;

D O I：

10.3233/JPD-150660

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Type 1 Gaucher's disease (GD1) is traditionally regarded as "non-neurological". Spatiotemporal and kinematic analysis of gait was carried on thirteen GD1 patients and thirteen healthy controls. We identified a previously unknown subclinical reduction of amplitude of movements in GD1. Articular excursion of ankle, knee and hip was reduced during the swing phase of gait (p<0.0001). Furthermore, the excursion of the knee appeared also significantly more asymmetric in GD1 patients (p = 0.02). Correction for age, BMI and basal walking speed did not modify the significance. Accordingly to the recent observations that GD1 predisposes to Parkinson's disease, the impaired and asymmetric gait kinematics that we observed might be interpreted as a form of extrapyramidal involvement.

引用

页码：191 / 195

页数：5

共 50 条

[21] The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG)
Cherin, P.
Rose, C.
de Roux-Serratrice, C.
Tardy, D.
Dobbelaere, D.
Grosbois, B.
Hachulla, E.
Jaussaud, R.
Javier, R. -M.
Noel, E.
Clerson, P.
Hartmann, A.
JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 (04) : 331 - 338
[22] Eliglustat: A Review in Gaucher Disease Type 1
Scott, Lesley J.
DRUGS, 2015, 75 (14) : 1669 - 1678
[23] Jaws Features in Type 1 Gaucher Disease
Zeevi, Itai
Anavi, Yakir
Kaplan, Ilana
Zadik, Yehuda
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2013, 71 (04) : 694 - 701
[24] GLYCOSYLATED FERRITIN IN TYPE 1 GAUCHER DISEASE
Stirnemann, J.
Heraoui, D.
Boutenn, A.
Fain, O.
Fantin, B.
Belmatoug, N.
CLINICAL THERAPEUTICS, 2009, 31 : S208 - S209
[25] Hyperferritinemia and diagnosis of type 1 Gaucher disease
Marchi, Giacomo
Nascimbeni, Fabio
Motta, Irene
Busti, Fabiana
Carubbi, Francesca
Cappellini, Maria Domenica
Pietrangelo, Antonello
Corradini, Elena
Piperno, Alberto
Girelli, Domenico
AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (05) : 570 - 576
[26] A therapeutic model for type 1 Gaucher disease
Enquist, I. Berglin
Nilsson, E.
Ooka, A.
Mansson, J. E.
Olsson, K.
Ehinger, M.
Richter, J.
Karlsson, S.
EXPERIMENTAL HEMATOLOGY, 2006, 34 (09) : 49 - 49
[27] Life expectancy in Gaucher disease type 1
Weinreb, Neal J.
Deegan, Patrick
Kacena, Katherine A.
Mistry, Pramod
Pastores, Gregory M.
Velentgas, Priscilla
vom Dahl, Stephan
AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (12) : 896 - 900
[28] Type 1 nonneuronopathic Gaucher disease in children
Kaplan, Paige
CLINICAL THERAPEUTICS, 2007, 29 : S101 - S102
[29] Bone density in Type 1 Gaucher disease
Pastores, GM
Wallenstein, S
Desnick, RJ
Luckey, MM
JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 (11) : 1801 - 1807
[30] Are There Neurological Symptoms in Type 1 of Gaucher Disease?
Alaei, Mohammadreza
Jafari, Narjes
Rohini, Farzaneh
Ahmadabadi, Farzad
Azadi, Rezvan
IRANIAN JOURNAL OF CHILD NEUROLOGY, 2018, 12 (02) : 99 - 106

← 1 2 3 4 5 →